| FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. | prostate, |
| FOXO1 serves as a tumor suppressor in endometrial cancer cells and is involved in normal growth control and maintenance of genomic stability. | endometrial, |
| Inhibition of miR-96 caused expression increase of tumor suppressor gene FOXO1; miR-96 may play a vital role in promoting cell proliferation in human prostate cancer cells | prostate, |
| FOXO1 is a tumor suppressor in cervical cancer | cervical, |
| our study revealed miR-411 promoted cell proliferation of lung cancer by targeting tumor suppressor gene FOXO1 and miR-411 might be a potential target for lung cancer therapy. | lung, |
| A transcriptional network involving the tumor suppressors Kruppel-like factor 6 and forkhead box O1 negatively regulate activated EGFR signaling in both cell culture and in vivo cancer models | None |
| FOXO1 as a tumor suppressor inactivated via AR/ER? signals in urothelial cells | None |
| An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene. | sarcoma, |
| QKI-mediated repression of FOXO1 may be one of the factors contributing to the oncogenesis and progression of breast carcinoma. | breast, |
| Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options. | sarcoma, |
| FOXO1 gene expression is elevated in cervical cancer and cervical intraepithelial neoplasia.An oncogenic role of FOXO1 in cervical cancer cells that correlates with poor patient survival. | cervical, |
| cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. | None |
| Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene. | None |
| Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein. | None |
| Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein. | None |
| data suggest that phosphorylation-dependent degradation of FoxO1 by means of proteasomes plays a role in oncogenic transformation by P3k and Akt | None |
| Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein. | None |
| PAX3-FKHR chimeric oncoprotein: hiding itself from immune detection?. | None |
| Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoprotein. | None |
| The oncogenic transcription factor PAX3-FKHR can convert fibroblasts into contractile myotubes. | None |